Loading…
Aardvark Therapeutics, Inc. is projected to rise to $7.69 by 2027, a +17% move from its current price of $6.60. AARD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $6.09 | $6.60 | $7.16 | +0.06% |
| Aug 5 | $5.89 | $6.61 | $7.41 | +0.12% |
| Aug 6 | $5.75 | $6.61 | $7.61 | +0.18% |
| Aug 7 | $5.63 | $6.62 | $7.78 | +0.24% |
| Aug 8 | $5.52 | $6.62 | $7.94 | +0.30% |
| Aug 9 | $5.43 | $6.62 | $8.08 | +0.36% |
| Aug 10 | $5.35 | $6.63 | $8.21 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.35 | $6.63 | $8.21 | +0.42% |
| Week 2 | $4.91 | $6.66 | $9.01 | +0.85% |
| Week 3 | $4.61 | $6.68 | $9.69 | +1.28% |
| Week 4 | $4.37 | $6.71 | $10.31 | +1.71% |
| Week 5 | $4.17 | $6.74 | $10.89 | +2.14% |
| Week 6 | $4.00 | $6.77 | $11.45 | +2.57% |
| Week 7 | $3.85 | $6.80 | $11.99 | +3.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aardvark Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
The company was incorporated in 2017 and is headquartered in San Diego, California.
It is categorized in Healthcare.
Aardvark Therapeutics, Inc. trades under the symbol AARD and operates within the Healthcare category. The current price is $6.40.
A major floor 64.0% below — a decisive break under it would weaken the trend.
The nearest floor, 40.5% below — buyers have tended to step in here.
The nearest ceiling, 15.2% above — a clean break opens room to run.
A major ceiling 47.2% above — clearing it would confirm fresh momentum.
Key AARD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AARD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.29 | Buy | $6.31 | Buy |
| MA 10 | $6.22 | Buy | $6.24 | Buy |
| MA 20 | $6.13 | Buy | $6.01 | Buy |
| MA 50 | $5.01 | Buy | $5.59 | Buy |
| MA 100 | $4.95 | Buy | $6.12 | Buy |
| MA 200 | $8.55 | Sell | $7.65 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.15 | Neutral |
| Stoch RSI (14) | 67.12 | Neutral |
| CCI (20) | 66.26 | Neutral |
| Williams %R (14) | -6.57 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -1.05 | Sell |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 93.43 | Sell |
| TRIX (15) | 1.11 | Buy |
| Awesome (5,34) | 0.78 | Buy |
| Ultimate (7,14,28) | 53.90 | Neutral |
| Momentum (10) | 0.74 | Buy |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 6.10 | Buy |
| ADX (14) | 16.18 | Neutral |
| ATR (14) | 0.47 | Info |
Sentiment is BULLISH. The RSI14 is 50, with a SMA50 of $4.97 and a SMA200 of $8.59. Support is listed at $3.82 and resistance at $7.60, framing a 30-day range from $3.69 to $11.09.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.48 | $6.60 | $9.46 | 0% | Neutral | |
| $5.60 | $7.69 | $11.41 | +17% | Neutral | |
| $6.06 | $8.85 | $14.01 | +34% | Bullish | |
| $5.47 | $8.41 | $13.99 | +27% | Bullish | |
| $8.07 | $13.03 | $22.55 | +97% | Bullish | |
| $10.73 | $18.09 | $32.43 | +174% | Bullish | |
| $10.42 | $18.32 | $33.88 | +178% | Bullish | |
| $12.33 | $22.59 | $42.93 | +242% | Bullish | |
| $12.11 | $23.07 | $44.97 | +250% | Bullish | |
| $10.47 | $20.74 | $41.37 | +214% | Bullish | |
| $19.29 | $42.88 | $94.03 | +550% | Bullish | |
| $32.64 | $72.53 | $166.82 | +999% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.48 | $6.60 | $7.86 | +0.00% |
| September 2026 | $5.23 | $6.36 | $8.08 | -3.58% |
| October 2026 | $5.66 | $6.97 | $9.03 | +9.60% |
| November 2026 | $5.82 | $7.26 | $9.55 | +4.03% |
| December 2026 | $5.62 | $7.08 | $9.46 | -2.36% |
Click any year to see its month-by-month AARD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Aardvark Therapeutics, Inc.'s 2026 outlook centres on $6.60, within a $3.48 to $9.46 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, AARD could reach as high as $11.41, with a base case around $7.69 and support toward $5.60 — roughly +17% from $6.60. Price action looks broadly range-bound.
Expect AARD to range from $6.06 to $14.01 through 2028. The $8.85 average target implies a +34% move from current prices. That is up +15% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The AARD price prediction for 2029 points to an average of $8.41 (low $5.47, high $13.99) — a potential gain of +27% on today's $6.60. Momentum favours further upside here.
In 2030, AARD is projected to trade between $8.07 and $22.55, averaging $13.03 — a potential gain of +97% from today's $6.60. That is up +55% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Aardvark Therapeutics, Inc.'s 2031 outlook centres on $18.09, within a $10.73 to $32.43 range. That is up +39% on the projected 2030 average. That marks a +174% change versus current levels. Momentum favours further upside here.
By 2032, AARD could reach as high as $33.88, with a base case around $18.32 and support toward $10.42 — roughly +178% from $6.60. Buyers look set to stay in control over this stretch.
Expect AARD to range from $12.33 to $42.93 through 2033. The $22.59 average target implies a +242% move from current prices. That is up +23% on the projected 2032 average. Momentum favours further upside here.
The AARD price prediction for 2034 points to an average of $23.07 (low $12.11, high $44.97) — a potential gain of +250% on today's $6.60. Buyers look set to stay in control over this stretch.
In 2035, AARD is projected to trade between $10.47 and $41.37, averaging $20.74 — a potential gain of +214% from today's $6.60. That is -10% versus the projected 2034 average. Momentum favours further upside here.
Aardvark Therapeutics, Inc.'s 2040 outlook centres on $42.88, within a $19.29 to $94.03 range. That is up +107% on the projected 2035 average. That marks a +550% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, AARD could reach as high as $166.82, with a base case around $72.53 and support toward $32.64 — roughly +999% from $6.60. Momentum favours further upside here.
Investing $1,000 in AARD today (≈ 151.515152 AARD) could be worth
$10,989.26
+$9,989.26 (+999%) by 2050 · US Dollar
Based on the average projected AARD price of $72.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AARDwould be worth at today's price.
$1,000 invested in AARD on Jul 31, 2025 (≈ 83.263945 AARD) would be worth
$549.54
-$450.46 (-45.0%) today · 0.55× · US Dollar
Based on a AARD entry price of $12.01 vs. today's $6.6.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.32 | $1,044.3 | +4.4% |
| 1 month ago | $5.62 | $1,174.38 | +17.4% |
| 3 months ago | $5.46 | $1,208.79 | +20.9% |
| 6 months ago | $13.3 | $496.24 | -50.4% |
| 1 year ago | $12.01 | $549.54 | -45.0% |
| All time (1.5y) ago | $14.31 | $461.22 | -53.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AARD forecast.
Our base-case forecast reaches $13.00 around 2030.
Implied market cap at $13.00: $284.49M
Forecasts show a multi-year path of upside. For 2026 the avg is $6.40, with a min of $3.48 and a max of $9.15 and neutral sentiment. In 2027 the avg is $7.40 (min $5.39, max $10.99) with a neutral sentiment and 15.7% ROI.
The 2028 forecast is avg $8.40 (min $5.75, max $13.30) with 31.2% ROI and a bullish stance; 2029 shows avg $7.93 (min $5.16, max $13.20) with 24% ROI and bullish sentiment. By 2030 the avg is $12.21 (min $7.57, max $21.15) with 90.8% ROI and bullish sentiment. The path continues through 2031–2035 with rising medians: 2031 avg $16.75 (max $30.04; ROI 161.7%), 2032 avg $16.96 (max $31.37; ROI 165%), 2033 avg $21.04 (max $40.01; ROI 228.8%), 2034 avg $21.21 (max $41.36; ROI 231.4%), and 2035 avg $18.90 (max $37.72; ROI 195.4%).
For the 2040 horizon, the avg is $38.64 (min $17.39, max $84.74) with 503.7% ROI and bullish sentiment, and by 2050 the avg is $64.73 (min $29.13, max $148.87) with 911.3% ROI and bullish sentiment.
Tap a question to reveal the answer.
2030 avg $12.21, min $7.57, max $21.15; ROI 90.8%; sentiment BULLISH.
Forecasts show rising averages and bullish sentiment from 2028 onward, with ROIs including 2027 15.7%, 2028 31.2%, 2029 24%, 2030 90.8%, 2031 161.7%, 2032 165%, 2033 228.8%, 2034 231.4%, 2035 195.4%, 2040 503.7%, and 2050 911.3%.
Yes. The 2050 max is $148.87, with an avg of $64.73.
Current price is $6.40 and market cap is $140.06M.
Sentiment BULLISH. RSI14 is 50; SMA50 is $4.97; SMA200 is $8.59. Support is $3.82 and resistance is $7.60. The 30-day range is $3.69 to $11.09.
Aardvark Therapeutics, Inc. Community Discussion
0Share your Aardvark Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.